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Ulcerative colitis developing after amoebic dysentery
in a haemophiliac patient with AIDS
I Sturgess, S M Greenfield, J Teare, M J O'Doherty
Abstract
Severe diarrhoea in patients with the acquired
immune deficiency syndrome (AIDS) is
usually a manifestation of gastrointestinal
infection by a variety of organisms. We report
a patient with low CD4 T celi counts who
developed ulcerative colitis after amoebic
dysentery. He subsequently developed acute
ulcerative colitis with toxic dilatation while
he was severely immunocompromised. He
responded to corticosteroids and mesalazine
and remains well on maintenance therapy.
Diarrhoeal illness is a common occurrence in
patients with the acquired immune deficiency
syndrome (AIDS). This is frequently the result
of infection with opportunistic organisms,
although diarrhoea without infection does occur
as part of chronic human immunodeficiency
virus (HIV) infection. We report a heterosexual
man with haemophilia who presented with toxic
megacolon secondary to ulcerative colitis and
responded to steroids and mesalazine. To deter-
mine the extent of his colitis an "'Indium oxine
labelled leukocyte scan was performed, but in
view of his neutropaenia donor leukocytes were
used. To our knowledge, this is the first case of
severe ulcerative colitis developing in an HIV
infected patient with such severe immuno-
suppression.
with bloody diarrhoea. He was passing up to 10
fluid motions per day, and the diarrhoea had
worsened progressively over the preceding three
weeks despite a course of metronidazole two
weeks before admission to hospital. The bleeding
responded to repeated Factor VIII cover but his
diarrhoea continued unabated. He had general
malaise and anorexia and had lost 6 kg in weight.
He was feverish, with temperatures up to 38-5C.
There was generalised colicky abdominal pain
and distension, particularly in the upper part of
his abdomen. He was tender to palpation in the
left iliac fossa and bowel sounds were increased.
Investigations at this time showed a
haemoglobin concentration of 10@1 g/100 ml, a
white cell count of 2 6x109 (neutrophils 2- 1x
109/1, lymphocytes 0 4x109/l, CD4 0 17x109/l,
and a CD4/CD8 ratio of 0 40). Plain abdominal x
ray showed faecal loading of the right hemicolon
but no gross dilatation. Repeated stool cultures
and examination failed to identify any patho-
gens, particularly Mycobacterium tuberculosis,
Cryptosporidium, Toxoplasma, Entamoeba,
Microsporidium, Salmonella, and Shigella. No
viruses were seen on electron microscopy nor
was cytomegalovirus grown or identified using
immunofluorescence from stools, urine, throat
swab, or blood. Sigmoidoscopy at this time
showed an acutely inflamed rectal mucosa with
some contact bleeding. Biopsy specimens taken


















A 44 year old heterosexual man with haemophilia
who had had chronic HIV infection since 1984
presented to St Thomas's Hospital in February
1989 with diarrhoea. At that time Entamoeba
histolytica was isolated and the diarrhoea res-
ponded to a course of tinidazole. There was a
history of recent travel to Hong Kong, which
accounted for his development of amoebic
dysentery. He presented again in March 1989
with a further diarrhoeal illness and a weight loss
of 3 kg. On this occasion, although no pathogens
were isolated from the stool, metronidazole was
given at a dose of 400 mg three times daily for 10
days. A sigmoidoscopy showed mild proctitis
without ulceration and the rectal biopsy specimen
showed a florid proctocolitis with crypt abscess
formation Culture and immunofluorescence for
cytomegalovirus were negative. At that time his
CD4 counts were 0 22 x 109/l with a CD4/CD8
ratio of 0-47. In view of his diarrhoea and weight
loss his disease was classified as Communicable
Disease Centre stage 4a.' He was begun on
zidovudine (AZT) which resulted in improve-
ment in his symptoms, with increased weight
and resolution of his diarrhoea.
In late December 1989, he presented again
I".Bl.:. S -..1
Figure 1: Rectal biopsy specimen showing marked acute
inflammatory infiltrate ofthe lamina propria with extension
into crypts andfocal crypt abscessformation. (Original
magnification x400.)
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Figure 2: An "'Indium labelled donor leukocyte scan showing a pancolitis. Reproduced with
kind permission ofProfessorE I, Editor, European Journal Nuclear Medicine.
cytomegalovirus infection, and showed histo-
logically an acute neutrophil infiltration with
crypt abscess formation (Fig 1). No inclusion
bodies were seen nor was Cryptosporidium
identified. An "'In oxine labelled donor leuko-
cyte scan (Fig 2) showed a pancolitis without
abscess formation.
Because of his clinical state, intravenous
gancyclovir was begun on the presumptive diag-
nosis of cytomegalovirus colitis while the above
results were awaited. Over the next 48 hours his
clinical state deteriorated with a rising tempera-
ture, tachycardia, and a reduction in the stool
frequency. A plain abdominal film at this time
showed toxic dilatation of the colon (Fig 3).
Because of this and the repeatedly negative
microbiological and virological studies, treat-
ment with 100 mg of intravenous hydrocortisone
six hourly was begun. Broad spectrum anti-
biotics were also started. On this regimen his
symptoms rapidly settled, with resolution of his
fever and reduction in the dilatation of his colon
on serial x ray examination (Fig 3). Mesalazine,
at a dose of 400 mg three times daily, was begun
48 hours after the steroids. After a further 48
hours of this regimen the gancyclovir was
stopped, without any deterioration in the
patient's clinical state. Repeat studies for cyto-
megalovirus were again negative. Conversion to
oral prednisolone, with a progressive reduction
in dosage to 10 mg daily, and an increase to
800 mg three times daily of mesalazine over the
ensuing two months has maintained remission.
In this patient a clinical diagnosis of ulcerative
colitis was guided by a poor response to antiviral
treatment, positive histology, an "'In labelled
leukocyte scan compatible with ulcerative colitis,
and the rapid onset of toxic megacolon.
Colonoscopy, performed two months after
hospital discharge, showed a quiescent colitis
from the distal transverse colon to the rectum.
Multiple biopsy specimens taken at this examin-
ation did not show any evidence of cytomegalo-
virus colitis. There was evidence of a continuing,
although mild, colitis and no histological
evidence of Kaposi's sarcoma could be detected.
Figure 3A
Figu,re 3B
Figure 3: (a) Plain abdominal x ray with toxic dilatation
affecting the transverse colon. (b) Repeat abdominalfilm after
five days ofintravenous hydrocortisone showing resolution of
the toxic dilatation.
There remains no evidence of cutaneous or
oropharyngeal Kaposi's sarcoma.
Discussion
The occurrence of ulcerative colitis in a patient
with AIDS presents a difficult diagnostic
problem, particularly when the clinical state is
rapidly deteriorating before the results of full
microbiological investigations have been
obtained.
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The aetiology of ulcerative colitis is still
unknown, as are the initiating immunological
events in the development of the inflammatory
process. It is ofinterest that our patient developed
his ulcerative colitis after infection with
Entaemoeba histolytica. This association has been
previously reported,2 although the mechanism
remains elusive. It seems, however, that an
intact CD4 T cell system is not necessary for this
to initiate ulcerative colitis.
Previous reports of inflammatory bowel
disease in patients with chronic HIV infection
have included the remission of Crohn's disease
with HIV infection.3 This patient had an 18 year
history of recurrent relapses in his Crohn's
colitis, his disease became quiescent when his
CD4 T cell count dropped to 0-41 x I0/1. The
author suggested that CD4 T cells and an intact
immune response play a central role in the
pathogenesis ofCrohn's disease. This is unlikely
to be so in ulcerative colitis since our patient
developed his disease while he was severely
immunocomprised: his CD4 T cell count was
0-22 x 109/1. In addition T lymphocyte studies in
ulcerative colitis have shown reductions in the
overall numbers of both CD4 and CD8 cells in
the peripheral blood and the ratio between them
is preserved suggesting that T lymphocytes do
not have a role in the inflammatory process.4
However, others have suggested a role for
activated T cells.5
Ulcerative colitis has been reported once
previously in a patient with chronic HIV
infection,6 although this patient was not
immunocompromised. The other reports of
severe ulcerative colitis in homosexual AIDS
patients showed that they had Kaposi's sarcoma
of the bowel.78 In both these cases an initial
diagnosis of ulcerative colitis was made, but
there was incomplete control ofsymptoms and in
one the development of a toxic megacolon
required colectomy resulting in the correct
diagnosis being made. Both these patients
developed cutaneous Kaposi's sarcoma soon after
beginning steroids. In our patient, despite an
exhaustive search, we have been unable to detect
any evidence of Kaposi's sarcoma, although he
will remain under colonoscopic surveillance.
The resolution of symptoms with weight gain
and continuing improved health three months
after his episode of toxic dilatation suggest an
episode of acute ulcerative colitis without any
underlying Kaposi's sarcoma.
The use of an "'In oxine labelled donor
leukocyte scan as a relatively non-invasive means
of determining the extent of this patient's colitis
is of particular interest. There have been no
previous reports of donor leukocyte scans in
AIDS patients, although autologous cells have
been used. This donor cell technique seems to be
safe for both the patient and the technician
labelling the cells.9 In this patient the use of a
donor leukocyte scan effectively showed the
extent of the inflammatory process in the colon.
The scan showed a pancolitis at the time of
presentation, while a later colonoscopy showed a
mild colitis affecting the transverse, descending,
and sigmoid colon.
Our patient shows that ulcerative colitis can
develop in patients with severe immuno-
suppression. Obviously, we will need to screen
this patient continually for the development of
colonic and extracolonic Kaposi's sarcoma,
although previous reports have only shown this
complication in homosexual AIDS patients. We
would suggest that AIDS patients who develop
ulcerative colitis should have colonoscopy and
deep biopsy specimens taken six monthly or
whenever there is a relapse. In this group of
patients there is still the possibility that develop-
ment of acute diarrhoea may be due to bacterial,
viral, fungal, or protozoal infection as well as a
relapse of ulcerative colitis.
In conclusion, this patient represents the first
case of the development of ulcerative colitis with
toxic dilatation in a patient with AIDS and adds
another differential diagnosis to the list of causes
of diarrhoea in these patients.
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